Literature DB >> 9928685

Pediatric sedation with analgesia.

L A Bauman1, I Kish, R C Baumann, G D Politis.   

Abstract

Sedation with analgesia is frequently required to perform painful or invasive procedures in children. The best medication combination for pediatric sedation with analgesia is yet to be identified. Sixty-four of 243 total sedation with analgesia procedures from January 1994 through August 1995 were randomly chosen for descriptive retrospective review and analysis. Four minor complications from the procedures were identified, and recovery was complete in all cases. One medication combination (fentanyl 1 microg/kg with propofol 1.5 to 2 mg/kg, followed by an infusion of 150 microg/kg/min) provided the shortest mean time to dismissal (17.8 minutes v 38 minutes) when compared with other combinations used. No episodes of respiratory depression, hypotension, or nausea and vomiting occurred in the fentanyl/propofol group. These results show that fentanyl/propofol was superior to other medications used during this study period for pediatric sedation with analgesia. Prospective comparison of this medication combination with other short-acting agents in patients undergoing both elective and emergency procedures is necessary.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9928685     DOI: 10.1016/s0735-6757(99)90001-3

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  2 in total

1.  Outcome of pediatric procedural sedation & analgesia in a tertiary care hospital in Pakistan.

Authors:  Humaira Jurair; Amyna Bhimani
Journal:  Pak J Med Sci       Date:  2015 Nov-Dec       Impact factor: 1.088

2.  Investigation of the effects of propofol/ketamine versus propofol/fentanyl on nausea- vomiting administered for sedation in children undergoing magnetic resonance imaging: a prospective randomized double-blinded study

Authors:  Hacı Semih Gürcan; Ayşe Ülgey; Özlem Öz Gergin; Sibel Seçkin Pehlivan; Karamehmet Yıldız
Journal:  Turk J Med Sci       Date:  2021-08-30       Impact factor: 0.973

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.